MapLight Therapeutics, Inc. Common Stock (MPLT) — Long-term Investment Intensity
MapLight Therapeutics, Inc. Common Stock (MPLT) has a Long-term Investment Intensity of 30.9% as of December 2025. Long-term investments of $147.99 Million represent 30.9% of total assets of $479.51 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See MapLight Therapeutics, Inc. Common Stock shareholders equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
MapLight Therapeutics, Inc. Common Stock Long-term Investment Intensity (2025–2025)
This chart shows how MapLight Therapeutics, Inc. Common Stock's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of December 2025, the intensity stands at 30.9%, reflecting long-term investments of $147.99 Million against total assets of $479.51 Million USD. Also explore MapLight Therapeutics, Inc. Common Stock total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for MapLight Therapeutics, Inc. Common Stock (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for MapLight Therapeutics, Inc. Common Stock from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see MapLight Therapeutics, Inc. Common Stock (MPLT) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 30.9% | $147.99 Million | $479.51 Million | — |